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a b s t r a c t
Marek's disease virus (MDV) is a widespread α-herpesvirus of chickens that causes T cell tumors. Acute,
but not latent, MDV infection has previously been shown to lead to downregulation of cell-surface MHC
class I (Virology 282:198–205 (2001)), but the gene(s) involved have not been identiﬁed. Here we
demonstrate that an MDV gene, MDV012, is capable of reducing surface expression of MHC class I on
chicken cells. Co-expression of an MHC class I-binding peptide targeted to the endoplasmic reticulum
(bypassing the requirement for the TAP peptide transporter) partially rescued MHC class I expression in
the presence of MDV012, suggesting that MDV012 is a TAP-blocking MHC class I immune evasion
protein. This is the ﬁrst unique non-mammalian MHC class I immune evasion gene identiﬁed, and
suggests that α-herpesviruses have conserved this function for at least 100 million years.
& 2014 Elsevier Inc. All rights reserved.
Introduction
The immune response to viral infection usually eliminates
infection and protects against subsequent infection. However, a
number of viruses are able to establish long-term infections in
spite of the immune response. In particular, members of the
herpesvirus family are able to establish latent infections and
reactivate in spite of a functional immune response. The mechan-
isms underlying this ability are not well understood.
Another general feature of herpesviruses is their ability to block
the class I major histocompatibility complex (MHC class I) antigen
presentation pathway. MHC class I is expressed on the surface of
almost all nucleated cells, and consists of a trimolecular complex
composed of the highly polymorphic MHC class I heavy chain, β2-
microglobulin (β2-m), and a small peptide, usually 8–10 amino
acids long. These peptides are generated by proteolysis in the
cytosol, mainly by the proteasome (reviewed in Rock et al. (2004),
Shastri et al. (2002)), and a small fraction of cytosolic peptides are
translocated into the endoplasmic reticulum (ER) lumen by the
transporter associated with antigen presentation (TAP). Newly
synthesized heavy chain and β2-m assemble together to form a
dimer, a process that is facilitated by chaperones such as BiP,
calnexin, and calreticulin (Rufer et al., 2007; reviewed in Hulpke
and Tampe (2013)). After a peptide is loaded onto this dimer, the
mature MHC class I complex is allowed to exit the ER and reach
the cell surface. If the peptide is derived from a non-self protein,
CD8þcytotoxic T lymphocytes (CTL), an important component of
the antiviral immune response, can recognize the MHC class I
complex, and respond by lysing the infected cell as well as
releasing cytokines that confer an antiviral state on local cells.
Since the ﬁrst identiﬁcation of a herpesvirus MHC class I
immune evasion gene in 1994 (York et al., 1994), genes that
interfere with MHC class I have been described in at least a dozen
other α-, β-, and γ-herpesviruses that infect humans, non-human
primates, mice, cattle, horses, deer, and cats (Fruh et al., 1999,
2002; Hudson et al., 2001; Hislop et al., 2007; Kleijnen et al., 1997;
Koppers-Lalic et al., 2008; Powers et al., 2008; Powers and Fruh,
2008; Verweij et al., 2011). As well, some members of several other
viral families, including poxviruses, adenoviruses, and lentiviruses,
also have MHC class I immune evasion genes.
Marek's disease virus (MDV) is a ubiquitous α-herpesvirus of
chickens that causes T-cell lymphomas in infected birds (reviewed
in Jarosinski et al. (2006)). First identiﬁed as a disease in 1907
(Marek, 1907), the virus was identiﬁed in 1967 (Churchill and
Biggs, 1967), and a vaccine was ﬁrst made available in 1970.
However (as with several vaccines against herpesviruses) the
vaccine prevents clinical symptoms, but does not prevent infection
or transmission of the virus. Probably because of selection for
increased transmission in the face of widespread non-sterilizing
vaccination, MDV strains have continually increased in virulence;
the original vaccine has twice had to be replaced by more effective
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vaccines (Gimeno, 2008; Nair, 2005). Selective pressures, including
vaccination, early cohort removal, and host genetic selection
(Gimeno, 2008; Nair, 2005; Atkins et al., 2013; Hunt and Dunn,
2013), may continue to drive increases in MDV virulence in the
future; and new vaccines will probably be required to handle
resulting outbreaks (Gimeno, 2008; Nair, 2005).
MDV has been shown to reduce MHC class I surface expression
in the acute, but not the latent, phase of infection (Hunt et al.,
2001; Levy et al., 2003). Although the UL49.5 gene of MDV was
shown to reduce expression of MHC class I expression in chicken
cells, this gene was found to be only partially responsible for the
MHC class I inhibition seen (Jarosinski et al., 2010), and additional
responsible gene(s) have not yet been identiﬁed. Homologs of
UL49.5 are conserved throughout the herpesvirus lineage, and
have been shown to have MHC class I evasion activity in several,
though not all, members of the Varicellovirus genus (Koppers-Lalic
et al., 2005, 2008; Verweij et al., 2011) and MDV (Jarosinski et al.,
2010). The UL49.5 genes of Varicelloviruses have been shown to
function through inhibition of TAP by several mechanisms
(Koppers-Lalic et al., 2008), while the mechanism of UL49.5
evasion of MHC class I in MDV is not yet known.
Here we identify an additional MDV gene that prevents MHC
class I expression, and demonstrate that the gene prevents trans-
port of cytosolic peptides to the ER but does not inhibit peptide
loading in the ER. This gene appears to be unique to the non-
mammalian Mardivirus clade, and, along with the identiﬁcation of
UL49.5, suggests that MHC class I immune evasion has been
functionally preserved in the α-herpesviruses for at least 100
million years.
Results
MDV012 reduces surface MHC class I on chicken cells
We transfected chicken DF1 and LMH cells with each of ten
cloned MDV genes, and stained cell-surface MHC class I two days
after transfection, gating on GFP-positive cells to limit analysis to
transfected cells. Most of the genes did not alter MHC class I
surface expression signiﬁcantly (Fig. 1A). UL49.5 is an MHC class I
immune evasion gene in several, but not all, α-herpesviruses, and
has been shown to moderately down-regulate MHC class I on
chicken OU2 cells (Jarosinski et al., 2010) in one report but had no
effect in LMH cells or human MJS cells in another report (Verweij
et al., 2011). In our experiments MDV UL49.5 did not consistently
reduce MHC class I expression on DF1 (Fig. 1A) or LMH cells (data
not shown). MDV087 consistently, but only slightly, reduced sur-
face MHC class I on DF1 cells (Fig. 1A) but had no consistent effect
in LMH cells (data not shown). In contrast, the viral gene MDV012
signiﬁcantly reduced MHC class I surface expression on DF1 cells
(Fig. 1A).
In the MDV genome, MDV012 is predicted to consist of two
exons separated by an 83-bp intron (with the 50 exon being termed
“MDV011” in some annotations), and our original clone of MDV012
from the BAC-encoded MDV genome included the intron (genomic
MDV012; “MDV012g”). To conﬁrm that MDV012 gene is spliced as
predicted, RT-PCR was performed on total RNA from chick embryo
ﬁbroblasts infected with the Md5 strain of MDV, using primers
from exon 1 and exon 2. The Md5 version of MDV012 and the
surrounding regions are identical to the Md11 version. A single
strong PCR product resulted which comprised exon 1 and exon
2 with the intron removed (data not shown), as predicted from the
genomic sequence. We cloned this spliced version of MDV012
(MDV012s), fused to GFP at the C-terminus. Expression of this
spliced MDV012s fusion construct had an even more dramatic
effect on surface expression of MHC class I than did expression of
MDV012g (Fig. 1A).
Chicken MHC class I genes, unlike most mammalian MHC class
I, includes only two isoforms and are closely linked to the TAP
genes (Kaufman et al., 1999). Of the two isoforms of MHC class I,
one is expressed more efﬁciently (major isoform) (Kaufman and
Salomonsen, 1997). The reason for this differential expression is
unknown, but the minor isoform may act as an NK cell ligand
(Ewald and Livant, 2004; O'Neill et al., 2009; Zhang et al., 2012).
Fig. 1. MDV012 reduces cell-surface MHC class I. (A) DF1 cells were transfected
with MDV genes as indicated, cloned into pEGFP-N1 (MDV012s) or pTracerCMV2
(all other genes). Two days after transfection the cells were stained for major MHC
class I isoform, and transfected cells (GFP positive) were analyzed by ﬂow
cytometry. Data are shown as mean ﬂuorescence intensity as a percent of cells
transfected with empty vector alone (average of at least three experiments7-
standard deviation). Samples in which the 95% conﬁdence interval does not overlap
100% are indicated with an asterisk (*). (B–D) DF1 (B, C) or LMH (D) chicken cells
were transfected with empty vector (thin trace) or with MDV012s (thick trace) and
stained for chicken MHC class I using (B) chicken antiserum speciﬁc for the major
allele of B21, (C) chicken antiserum speciﬁc for the minor allele of B21, or (D) a
monoclonal antibody speciﬁc for chicken MHC class I. Shaded trace: irrelevant
antibody (background staining). Each experiment is representative of at least three
replicates.
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We tested the effect of MDV012 on expression of the major and
minor isoform of B21 in DF1 cells, using chicken sera speciﬁc for
each isoform. The spliced version of MDV012 reduced expression
of both isoforms to similar extents (Fig. 1B and C). Unspliced
MDV012g did not have a consistent effect on the minor isoform of
B21 (data not shown), and the originally noted effect in DF1 cells
stained for the major isoform of B21 was mild and somewhat
variable in repeated experiments; thus splicing might be impor-
tant for gene function, although the difference in vectors used
preclude a direct comparison between spliced and unspliced
forms of this gene. MDV012s efﬁciently reduced cell-surface levels
of MHC class I on LMH cells (Fig. 1D).
MDV012 inhibition of MHC class I expression is speciﬁc
Cells transiently transfected with MDV012 showed no obvious
signs of toxicity. To test whether the effect on MHC class I
expression is speciﬁc, we co-transfected DF1 cells with MDV012s
(or with empty vector as a control) and either inﬂuenza HA, or
mouse H-2Kb expressed as a single chain fused with β2-m (“SC-
Kb”). Mammalian MHC class I heavy chain expressed in chicken
cells is expressed very inefﬁciently. However, in preliminary
experiments we determined that single-chain fusions of mamma-
lian MHC class I heavy chains fused to mammalian β2-m are
expressed effectively in chicken cells. Presumably the reason for
poor expression of mammalian MHC class I in chicken cells is that
chicken β2-m, which is only 45% identical to human and mouse
β2-m, does not bind efﬁciently to mammalian heavy chains.
Providing an appropriate binding partner in the form of mamma-
lian β2-m allows dimer formation and permits surface expression.
MDV012 reduced expression of endogenous chicken MHC, as
expected (Fig. 2A). MDV012 also reduced expression of co-
transfected SC-Kb (Fig. 2B). However, surface expression of HA
was not reduced by co-expression of MDV012 (Fig. 2C). This
observation shows that MDV012 does not non-speciﬁcally block
protein expression or cell-surface transport of glycoproteins. As
well, since MDV012 did block expression of mouse MHC class I as
well as endogenous chicken MHC class I, the effect of MDV012 on
surface expression of MHC class I must not be dependent on
chicken-speciﬁc MHC class I sequence or conformation.
MHC class I-binding peptide rescues expression of MHC class I
The TAP peptide transporter is a bottleneck in the antigen
processing pathway and is probably not required for cellular
processes other than MHC class I antigen presentation. Accord-
ingly, many mammalian herpesviruses target in TAP for evading
MHC class I. To test whether chicken TAP is a potential target for
MDV012, we used a peptide that has been shown to bind to the
chicken MHC class I B21 allele, REVDEQLLSV (R10V) (Koch et al.,
2007). We targeted the peptide to the ER lumen with a signal
sequence, or to the cytosol by expressing the peptide as a ubiquitin
fusion protein. Peptides fused to the C-terminus of ubiquitin are
rapidly cleaved by ubiquitin C-terminal hydrolases, releasing
ubiquitin and the C-terminal sequence as a cytosolic peptide with
a deﬁned N-terminus (Bachmair et al., 1986; York et al., 2006).
R10V targeted to the ER by a signal sequence (and thereby
bypassing the requirement for TAP) restored most of the MHC
class I surface expression on DF1 cells (which express B21)
(Fig. 3A), but did not affect surface expression of MHC class I in
LMH cells (whose MHC class I type is not B21, and which are
therefore not expected to bind R10V) (Fig. 3B). In contrast,
cytosolic expression of R10V did not rescue surface MHC class I
expression in DF1 or LMH cells (Fig. 3A, B). These experiments
suggest that MDV012 acts by blocking chicken TAP. Importantly,
the rescue of surface MHC class I expression in the presence of ss-
R10V further demonstrates that MDV012 does not prevent tran-
scription, translation, or surface expression of MHC class I, but
reduces surface expression by preventing newly-formed chicken
MHC class I in the ER from having access to peptide.
MDV012 orthologues are present in the Mardivirus clade
In MDV, MDV012 is a 489-amino acid protein that is encoded
by two exons separated by an 83-bp intron. Related proteins are
present in other members of the Mardivirus clade: Gallid Herpes-
virus 3 (GaHV-3; also known as Marek's disease virus type 2),
Meleagrid herpesvirus 1 (MeHV-1; also known as herpesvirus of
turkeys), and Duck Enteritis Virus (DEV) (Fig. 4). The MDV
(GenBank: NC_002229) and MeHV-1 (GenBank: NC_002641)
genes are annotated as spliced genes in at least some of the
genomic sequences. Although the GaHV-3 gene is not annotated as
spliced in the genomic sequence (GenBank: NC_002577), analysis
with splicing prediction programs (Hebsgaard et al., 1996) indi-
cates that this gene is also very likely to be spliced, extending the
similarity with GaHV-1 and MeHV-1 sequences. The DEV (Gen-
Bank: NC_013036) gene LORF3 has similarity to the second exon of
MDV012. However, we did not identify an obvious upstream exon
for this gene. Most of the similarity between these four proteins is
in the N-terminus, with the C-terminal half of the proteins being
Fig. 2. MDV012 reduces expression of H-2Kb, but not of inﬂuenza HA, in chicken
cells. DF1 cells were transfected with empty vector (thin traces) or with MDV012s
(thick traces) and co-transfected with (B) single-chain β2-m/H-2Kb fusion protein
(SC-Kb) or (C) with inﬂuenza hemagglutinin (HA). After two days, cells were
stained with (A) anti-major B21 chicken antiserum, (B) anti-H-2Kb (B8.24.3), or
(C) anti-HA (H36.5-4.2). Cells were gated on GFP to limit analysis to transfected
cells. Shaded traces: Irrelevant antibodies (background staining). Each experiment
is representative of at least three replicates.
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quite dissimilar. Infectious Laryngotracheitis virus (ILTV; also
known as GaHV-1) and Psittacid herpesvirus 1 (PsHV-1), members
of the Iltovirus clade of avian herpesviruses, do not have obvious
orthologues of MDV012.
Discussion
Here we demonstrate that Marek's disease virus, an α3-
herpesvirus of chickens that diverged from mammalian herpes-
viruses at least 100 million years ago (McGeoch et al., 2006),
encodes a gene (MDV012) that speciﬁcally blocks surface expres-
sion of MHC class I. The ability to block surface expression of MHC
class I has been previously shown for MDV (Hunt et al., 2001; Levy
et al., 2003), and while one partially responsible gene has been
identiﬁed, another gene(s) is expected to contribute signiﬁcantly
to this function (Jarosinski et al., 2010).
Our experiments suggest that MDV012 blocks antigen proces-
sing at the level of the TAP peptide transporter, a common target
of viral MHC class I immune evasion genes. In particular, the
MDV012-imposed block on surface expression of MHC class I
proteins is overcome when a peptide epitope binding the chicken
MHC class I is delivered into the ER, but not when the peptide is
delivered to the cytosol. This indicates that MDV012 does not post-
translationally destroy MHC class I or prevent its transcription,
translation, or trafﬁcking, but rather affects peptide availability
within the ER lumen.
Also consistent with a TAP blockade is the observation that
MDV012 reduces surface expression of both the major and minor
MHC class I isoforms. The function of minor isoforms of MHC class
I is not well understood. One possibility is that the minor isoform
of MHC class I acts as an inhibitory NK ligand (Ewald and Livant,
2004; O'Neill et al., 2009; Zhang et al., 2012); if so, the reduction in
the minor isoform by MDV012 may render cells susceptible to NK
recognition and lysis, unless, like many other herpesviruses, MDV
also has additional genes which block NK recognition of
infected cells.
MDV012 is a member of a small family of proteins with
unknown functions (the “DUF1509” superfamily) that are found
in several avian herpesviruses of the Mardivirus clade (GaHV-3,
DEV, and MeHV-1). It is not yet known if the DUF1509 proteins
encoded by these other viruses also have an immune-evasion
function, but if so MDV012 may be a part of another small cluster
of related immune-evasion genes in closely-related viruses. Aside
the members of the Mardiviruses, no proteins related to MDV012
have been identiﬁed.
The observation that Marek's disease virus is able to block MHC
class I expression suggests that MHC class I immune evasion has
been functionally conserved in the α-herpesviruses for at least 100
million years (McGeoch et al., 2006). Although it remains possible
that MHC class I immune evasion was independently invented by α-,
β-, and γ-herpesviruses, the widespread presence of MHC class I
immune evasion genes in β-, and γ-herpesviruses suggests that the
common ancestor of the α-, β-, and γ- herpesviruses, about 400
milllion years ago (McGeoch and Gatherer, 2005), had MHC class I
immune evasion genes. Analysis of α4-herpesviruses (e.g. ILTV virus
of chickens), which diverged from mammalian α-herpesviruses
about 200 million years ago (McGeoch et al., 2006), and especially
of herpesviruses of reptiles and ﬁsh (which diverged over 400 million
years ago (McGeoch and Gatherer, 2006), prior to the establishment
of distinct α, β, and γ lineages) will be necessary to determine how
ancient MHC class I immune evasion is.
Marek's disease is a major concern for the global poultry
industry. MDV strains vary widely in virulence, and new strains
have increased in virulence over time. However, the MDV012 gene
is identical in very virulent (Md5 strain, GenBank: AF243438.1),
virulent (RB-1B, GenBank: EF523390.1, and Md11, GenBank:
AY510475.1), mildly virulent (CU-2, GenBank: EU499381.1), and
vaccine (CVI988, GenBank: DQ530348.1) strains of MDV, suggest-
ing that MDV012 is unlikely to play a direct role in the differing
virulence of different ﬁeld isolates.
Over 20 billion doses of MD vaccine are given annually, but
although the vaccine protects against disease it does not confer
sterilizing immunity, leading to concerns that the vaccine itself
may be driving increased MDV virulence over time (Gimeno, 2008;
Nair, 2005). The presence of MDV012 in the widely-used vaccine
strain CV1988 raised the possibility that deleting MDV012 from
the virus may attenuate the virus as well as increase its immuno-
genicity; however, we found that deleting MDV012 from the Md5
strain of MDV by BAC mutagenesis made the virus non-viable in
tissue culture, conﬁrming another report that MDV012 is an
Fig. 3. B21-binding peptide (R10V) targeted to the ER, but not the cytosol, rescues
cell-surface expression of B21 in the presence of MDV012. (A) DF1 cells (B21þ) or
LMH cells (B21) were transfected with MDV012s (dark bars) or with empty vector
as a control (open bars), and co-transfected with either empty vector (“Ctrl”), with
the peptide R10V as a cytosolic ubiquitin fusion protein (“R10V”, cytosolic), or with
an ER-targeted version of R10V (“ss-R10V”). Two days later, the cells were stained
with anti-major B21 chicken serum (A) or with anti-chicken MHC class I (B) and
analyzed by ﬂow cytometry.
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essential gene for in vitro replication (Chattoo et al., 2006) and
suggesting that it may perform more than one function. A recent
report of mild viral attenuation by single-SNP incorporation into
non-coding regions of MDV012 without signiﬁcant loss of in vivo
replication suggests that it may be possible to study the function
(s) of this gene in vitro and in vivo using small mutations or gene
knockdown methods (Hildebrandt et al., 2014).
Resistance to MDV varies widely between different strains of
chickens, and resistance is linked to the B21 haplotype (Briles
et al., 1977; Hutt and Cole, 1947; Longenecker et al., 1977), likely
Fig. 4. MDV012 orthologs. MDV012-related proteins of Marek's disease virus (MDV), gallid herpesvirus 3 (GaHV3), meleagrid herpesvirus 1 (MeHV1), and duck enteritis
virus (DEV). Regions of identity are boxed. The junction between exons 1 and 2 in MDV, GaHV3, and DEV is indicated with an arrow.
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due at least in part to its broad peptide binding repertoire for MHC
class I presentation (Koch et al., 2007; Sherman et al., 2008).
Chicken MHC class I heavy chains are tightly linked to TAP genes
(Shaw et al., 2007), which are relatively variable between chicken
strains (Walker et al., 2005). Could resistance to MDV also be
associated with the relative afﬁnity of MDV012 to different TAP
alleles? While MDV012 seems to have a somewhat more marked
effect on surface expression of MHC class I in LMH (which are not
B21 haplotype) than on DF-1 cells (B21 haplotype), further
experiments will be necessary to test whether this is a general
effect and if it is relevant to MDV pathogenesis in natural
infections.
In general, the function of MHC class I immune evasion genes
in viral pathogenesis is poorly understood, mainly because of the
lack of suitable animal models. Mouse β- and γ-herpesviruses
(MCMV and MHV68, respectively) lacking MHC class I immune
evasion functions have been analyzed in their natural hosts
(Bennett et al., 2005; Stevenson et al., 2002a, 2002b). For MCMV,
the lack of MHC class I immune evasion was associated only with
increased titers of virus in salivary glands (Lu et al., 2006), but had
only a modest effect on immune responses, viral titers, viral
persistence in other tissues, or virulence (Gold et al., 2004;
Krmpotic et al., 1999; Doom and Hill, 2008). MHV68 lacking
MHC class I immune evasion was similar to wild-type virus during
acute infection of mice, but was more susceptible to immune
clearance during the latent phase (Bennett et al., 2005; Stevenson
et al., 2002a, 2002b).
Among the α-herpesviruses, the two MHC class I immune
evasion genes which have been studied in the natural host are
the UL49.5 genes of bovine herpesvirus type 1 (BHV-1) and of
MDV. In the case of BHV-1, deleting speciﬁc residues in the luminal
and cytoplasmic tail regions of UL49.5 allowed abrogation of TAP
inhibition without affecting replication in vivo or in vitro (Wei
et al., 2011, 2012). In calves, BHV-1 lacking class I immune evasion
was equally virulent to the wild-type virus, but elicited an earlier
adaptive immune response (Wei et al., 2012). Similarly, deleting
the cytoplasmic tail from MDV UL49.5 resulted in a virus with
partially reduced immune evasion activity but which retained
wild-type replication and virulence in the chicken, although the
immune response was not studied in this case (Jarosinski et al.,
2010). These studies indicate that MHC class I immune evasion is
not an essential function for replication, and deleting this function
might be a useful tool to increase the immunogenicity of live
vaccines against α-herpesviral diseases of domestic animals or
humans.
Although not studied in vivo in the natural host, the ICP47 gene
of the human α-herpesviruses HSV-1 and -2 blocks human TAP
in vitro (Hill et al., 1995), and an ICP47 knockout showed altered
neurovirulence in mice (Orr et al., 2005); however, ICP47 has poor
afﬁnity for mouse TAP (Tomazin et al., 1998), so this model is not
necessarily relevant to class I immune evasion. The other human
α-herpesvirus, VZV, which interferes with MHC class I maturation
and trafﬁcking via the ORF66 protein kinase (Eisfeld et al., 2007),
lacks a suitable animal model of infection. Thus, evidence for the
relative importance of this mechanism in α-herpesvirus infection
will likely have to be gained from studying animal diseases in their
natural hosts. The chicken is a particularly useful model, as it is
small, easily housed, available in inbred lines, and well-
characterized. Infection of chickens with MDV lacking functional
MHC class I evasion by MDV012 may prove useful for under-
standing the function of MHC class I immune evasion by α-
herpesviruses in pathogenesis.
Methods and materials
Plasmids and cloning
We identiﬁed 10 MDV genes that are conserved between MDV
strains and whose function has not been determined, and used
PCR to clone these genes from a bacterial artiﬁcial chromosome
(BAC) containing the genome of the virulent Md11 strain of MDV
(Niikura et al., 2006). The MDV genes are listed in Table 1; the
primers used to amplify each of the genes are listed in Table 2.
Genes were ampliﬁed using high-ﬁdelity polymerases (either Pfx
[Invitrogen, Carlsbad, CA] or Phusion polymerase [Finnzymes,
Table 1
Marek's disease virus candidate genes for MHC class I immune evasion. Marek's
disease virus genes that are conserved between virus strains, and for which no
function has been proposed, were cloned for assessment of MHC class I immune
evasion.
Gene Protein/comment
MDV002 Arg-rich protein, RLORF1
MDV009 Hypothetical protein
MDV012 MDV011 and MDV012 are spliced to form MDV012
MDV049.5 Transmembrane protein/immune evasion
in some varicelloviruses
MDV069 Hypothetical protein LORF4
MDV082 Hypothetical protein
MDV085 Hypothetical protein
MDV086 Cytoplasmic protein
MDV087 Related to G. gallus hypothetical protein LOC422090
MDV093 Hypothetical protein SORF4
Table 2
Primers used to amplify Marek's disease virus genes from the MDV genome.
Gene Primer 1 Primer 2
MDV002 gcgaattc GTGCACGGGGATCTGC gctctaga TATTGATGGTACTGTCGCCG
MDV009 cggggtacc GTGGCAAACCACGACTACCT gctctaga CATATCCGATTGGCTCACCT
MDV012g gcgaattc CGGTGCTTTGTACTTCCTACG gctctaga TGGATTTGCAATCACACAACA
MDV049.5 Provided by K. Osterreider, Cornell University
MDV069 gcgaattc GCCACCCTTAAGTCTTCGTG gctctaga TCTCAGATATGTCTTGTTAAAGTGTGG
MDV082 gcgaattc CGGAAGCGATACTACTGCTG gctctaga CGTAACATTCGAACAAGTACCAAG
MDV085 gcgaattc GCTTAACCGGCAGTACAGGA gctctaga CGATGTGCTGAAAGTCGAAA
MDV086 cggggtacc GGGCATGTCTGATCCTTCA gctctaga TGGGCTACAATTCCCTTTTG
MDV087 cggggtacc AGGCCATATCAGCTTTCACG gctctaga TCACGTGATATCCGGTCAAA
MDV093 gcgaattc CGCGTTACCTGCAATAATGA gctctaga TCATATCCCGACGATGAAAA
MDV012s CTCAAGCTTCGCCACCACCATGACTAGCGAGA-
GAGCTCTTACTCTCGCGCCTGGTAAAGTTTCGACGGCA-
GATATTTATGAAGCCGATTTCAGTTTCCGTCGT-
GAATTTGTACGCCAAATTTTACAACGATTATTCCCAAG-
GACCTT
CTCAAGCTTCGCCACCACCATGACTAGCGAGAGAGCTCT-
TACTCTCGCGCCTGGTAAAGTTTCGACGGCAGATATTTATGAAGCC-
GATTTCAGTTTCCGTCGTGAATTTGTACGCCAAATTTTACAACGAT-
TATTCCCAAGGACCTT
C. Hearn et al. / Virology 475 (2015) 88–95 93
Woburn, MA]) and subcloned into pTracerCMV2 (Invitrogen). Each
gene was completely sequenced to conﬁrm that no point muta-
tions were introduced during the cloning process.
To conﬁrm the spliced nature of the MDV012 gene, total RNA
was isolated from chick embryo ﬁbroblasts infected with the Md5
strain of MDV using the RNeasy kit (Qiagen, Valencia, CA). The RNA
was subjected to reverse transcriptase PCR using the OneStep RT-
PCR kit (Qiagen) with the following primers: 50-ATGACTAGCGA-
GAGAGCTCTTACTC-30 and 50–TTCATCATCTGAACTCGACAT-30, and
the product was completely sequenced.
The spliced MDV012-EGFP fusion construct (MDV012s) was
made by PCR ampliﬁcation of Md5 DNA. The 50 primer comprises
the entire ﬁrst MDV012 exon (109 bps) and the ﬁrst 19 base pairs
of the second exon. This primer also incorporates a Hind III site at
its 50 end to facilitate cloning. The 30 primer incorporates a BamHI
site, allowing cloning of the PCR product into pEGFP-N1 (Clontech,
Mountain View, CA), to construct a GFP fusion protein. Primer
sequences are shown in Table 1. The resulting MDV012-pEGFP was
sequenced to conﬁrm that no errors were introduced during
construction.
To construct plasmids expressing cytosolic and ER-targeted
B21-binding peptide REVDEQLLSV (Koch et al., 2007), we annealed
oligonucleotides and cloned them into a ubiquitin fusion vector,
pUG1 (York et al., 2006), or into a signal-sequence containing
vector (York et al., 2002), as previously described (York et al., 2002,
2006). The oligonucleotides are listed in Table 3.
Inﬂuenza hemagglutinin (HA) was subcloned into pTra-
cerCMV2 (pTracerCMV2-HA). A single-chain MHC class I dimer
comprising mouse β2-mb and the mouse MHC class I allele H-2Kb,
joined by a ﬂexible linker, and cloned into pTracerCMV2 (pTra-
cerCMV2-β2-mb-SC-Kb), has been previously described (York et al.,
2005). Plasmids expressing SIINFEKL (the H-2Kb-restricted immu-
nodominant peptide from ovalbumin) as cytosolic ubiquitin fusion
proteins (pUG-S8L) or targeted to the ER (ss-AS8L) have been
previously described (York et al., 2006; Hearn et al., 2009). MDV
UL49.5 cloned into pcDNA3 (Invitrogen) was kindly provided by K.
Osterreider (Cornell University) and has been previously described
(Jarosinski et al., 2010).
Cell lines and transfection
DF1 cells (chicken ﬁbroblasts, B21 haplotype [Himly et al.,
1998]) were provided by D. Foster (University of Minnesota).
LMH (chicken hepatocellular carcinoma cells, unknown haplotype
[Kawaguchi et al., 1987]) was provided by Marcia Miller (Beckman
Research Institute of City of Hope, Duarte, CA). Transfections were
performed using TransIT LT1 (Mirus, Madison, WI) according to
the manufacturer's instructions.
Antibodies and ﬂow cytometry
Two days after transfection, cells were trypsinized and stained
with the following antibodies: C6B12 (anti-chicken MHC class I
[Shamansky et al., 1988], obtained from The Developmental
Studies Hybridoma Bank, Iowa City, Iowa); chicken antiserum
speciﬁc for major or minor B21 (Fulton et al., 2001); anti-H2-Kb
(B8.24.3 [Kohler et al., 1981]); or anti-HA (H36.5-4.2; [Caton et al.,
1982]). Cells were washed in PBS, and counter-stained with
secondary antibodies. Cy5-conjugated second antibodies to mouse
or chicken antibodies were purchased from Jackson Immunore-
search (West Grove, PA). Flow cytometry was performed on a BD
LSRII or BD FACS Vantage (Becton Dickinson), live cell populations
were identiﬁed based on forward- and side-scatter characteristics,
and transfected cells were identiﬁed by gating on GFP-positive
cells.
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